Calcium/calmodulin‑dependent protein kinase II delta (CaMKIIδ) is a central regulator of cardiac excitation–contraction coupling and is chronically activated in multiple cardiac pathologies. Nitrosylation has been implicated in cardiac cell signaling and function in health and disease. We tested how S-nitrosylation at two known CaMKII sites alters kinase activation conformation and mobility. In intact cardiomyocytes, we monitored in real time, the activation state with GSNO treatment– before or after activation of CaMKII. Active CaMKII conformation was assessed using the fluorescent biosensor Camui and fluorescence lifetime values, and mobility was assessed by fluorescence recovery after photobleach (FRAP) in CaMKII-GFP. To test the influence of each known S-nitrosylation site we used CaMKII in which each site was mutated (Cys273Ser and Cys290Ala) in Camui and CaMKII-GFP. The results show for the first time in intact ventricular cardiomyocytes, that S-nitrosylation of CaMKII at Cys273 prior to electrical field stimulation (and β-adrenergic agonists), suppresses CaMKIIδ activation, and mobility, effects largely lost in Cys273Ser CaMKIIδ. In contrast S-nitrosylation of CaMKIId Cys290 was critical for GSNO-induced activation and mobility. Thus, baseline S-nitrosylation at Cys273 limits CaMKIIδ activation and mobility, while S-nitrosylation at C290 when the kinase is activated enhances activation and mobility.